KKR

Analyst Note: KKR & Co. Inc. (KKR)

Date: 2026-06-13 Event Date: 2026-06-13

1. Structural Readiness

The current setup for KKR is classified as a COIL family structure in an INVALIDATED state.

• Current Price: $97.01.
• Breakout Level: $153.87.
• Entry Status: No conservative entry is available. The aggressive entry level of $100.03 (pre-breakout) is no longer actionable as the structure has broken down.
• Extension: None recorded.
• ATR Context: Current ATR is 3.6% (productive), indicating active volatility, but the structural invalidation overrides volatility-based sizing in this instance.

2. Thesis Layer

As of 2026-06-13, there is NO named secular thesis attached to this setup. This is a TACTICAL, setup-led name.

• Judgment Criteria: The investment case must be judged strictly on the quality of the technical setup (which is currently failed) and the underlying business fundamentals.
• Constraint: No macro or thematic thesis should be invented to justify holding a technically invalidated position. The absence of a named thesis means conviction must rely entirely on the strength of the business evidence and the potential for a future structural reformation, not on a pre-existing narrative.

3. Business Analysis

Company Overview: KKR & Co. Inc. is a prominent global investment powerhouse operating in private equity, real assets, and credit. The firm manages a diversified portfolio across corporate acquisitions, leveraged buyouts, growth equity, and special situations.

Business Model & Segments:

• Asset Management: The core business generates management fees based on Assets Under Management (AUM). As of the May 5, 2026 earnings call, management fees reached $1.2 billion for the quarter, a 30% year-over-year increase. This growth was driven by fundraising momentum and deployment activity.
• Capital Raising: The firm raised $28 billion of new capital in the quarter ending May 2026. Notably, the North America 14 fund closed at $23 billion, eclipsing the prior $19 billion fund. Inflows into the credit business more than doubled quarter-over-quarter.
• Fee Diversification: The fee base is balanced, with private equity, real assets, and credit each contributing approximately 1/3 of total fees over the trailing 12 months.
• Insurance (Global Atlantic): KKR operates a significant insurance business through Global Atlantic, which it fully acquired in January 2024. As of December 31, 2025, Global Atlantic contributed $219 billion to the firm's total AUM of $744 billion. The insurance subsidiary is strategically shifting capital into non-yielding or lower-yield asset classes like private equity and real assets to expand outside the U.S. and raise third-party co-investment capital.
• Portfolio Activity: Recent exits include the sale of OneStream Software for 4.5x cost and CoolIT Systems for almost 15x cost.
• Capital Structure: As of May 7, 2026, there were 897,872,941 shares outstanding. A structural change is scheduled for the "Sunset Date" (no later than December 31, 2026), where Series I preferred stock will be cancelled, voting rights will be equalized (one vote per share), and KKR will acquire control of the carry pool.

Management Expectations (Recorded as of May 2026): Management indicated that if monetization targets are missed in 2026, they expect delayed transactions to shift to 2027 and beyond, rather than being lost. They also noted meaningful inbound interest in their direct lending business due to dislocations in the private BDC space.

4. Archetype and Conviction

Archetype: Quality Compounder

• Fit: The business exhibits the characteristics of a Quality Compounder through its consistent fee growth (30% YoY), massive capital raising ($28B/quarter), and long-duration capital base (92% of AUM has a duration of at least eight years). The "skin in the game" is substantial, with approximately $30 billion invested or committed by the firm and its employees.
• Valuation Context: The financial spine indicates a forward consensus EPS of $6.03 for FY1 and $7.36 for FY2.
• Conviction Stack:
• Thesis Strength: Low (No named secular thesis; purely tactical).
• Evidence Quality: High. Strong earnings data, clear AUM growth, and transparent capital structure changes.
• Structural Quality: The business fundamentals are robust, but the setup readiness is zero due to the invalidated coil.
• Rerating Potential: Dependent on the technical structure reforming. The current price action ($97.01) is below the invalidation line ($97.43), suggesting immediate selling pressure or consolidation below the previous support.
• ATR Context: The current ATR of 3.6% is in the "productive" range (historical sweet spot 4-6%), but the structural break suggests the volatility is currently working against the long thesis.

5. Invalidating and Strengthening Factors

Invalidation:

• Fundamental: Any evidence of a contraction in the fee base or a failure to raise capital in the credit segment (which saw inflows double QoQ) would weaken the "Quality Compounder" narrative.

Strengthening:

• Fundamental: Continued success in the "Sunset Date" restructuring (voting rights equalization) and the successful monetization of the OneStream/CoolIT exits shifting to 2027 as management expects.

Evidence Gaps:

• Missing: There is no specific evidence regarding the *immediate* impact of the current price drop on the insurance subsidiary's capital ratios or the specific timeline for the "Sunset Date" execution beyond the December 31, 2026 deadline.
• Missing: No data on the specific valuation multiples applied to the new credit fundraising compared to historical norms.

PRIVATE ANALYST CALL

Judgment: Sell Confidence: high Key risks: Management expectations of delayed monetization shifting to 2027 may not materialize if market conditions worsen; Insurance subsidiary unrealized losses on below investment grade securities ($324.2M) could pressure capital if rates remain volatile; Technical structure requires a reclaim of 97.43 to become actionable again. Sizing hint: Position size should be zero or reduced to cash; do not attempt to catch a falling knife on an invalidated coil. Expected path: Price likely to test lower support levels or consolidate below 97.43 until a new structural base forms; management expects delayed deals to shift to 2027, implying a longer timeline for capital deployment returns. Expected horizon: Indefinite until technical structure reforms; monitoring for a reclaim of 97.43. Failure mode to watch: A sustained close below 97.43 confirms the breakdown; failure to reclaim this level renders the setup non-actionable.